Dr. Brody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1190 5th Ave
New York, NY 10029Phone+1 212-241-6756Fax+1 212-423-0522
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
Yale-New Haven Medical CenterResidency, Internal Medicine, 2000 - 2003
Stony Brook University Health Sciences Center School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2003 - Present
NY State Medical License 2012 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma Start of enrollment: 2011 Feb 01
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers Start of enrollment: 2011 Oct 01
- In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy Start of enrollment: 2014 Jan 03
- Join now to see all
Publications & Presentations
PubMed
- 232 citationsFlow Sorting and Exome Sequencing Reveal the Oncogenome of Primary Hodgkin and Reed-Sternberg CellsJonathan Reichel, Amy Chadburn, Paul G. Rubinstein, Lisa Giulino-Roth, Wayne Tam
Blood. 2015-02-12 - 260 citationsCancer vaccines: the next immunotherapy frontier.Matthew J Lin, Judit Svensson-Arvelund, Gabrielle S Lubitz, Aurélien Marabelle, Ignacio Melero
Nature Cancer. 2022-08-01 - 48 citationsLow-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion.Michael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, Joshua D Brody, Aaron P Rapoport
Leukemia. 2022-07-01
Press Mentions
High-Dose Chemo, ASCT Improves Survival in Primary CNS LymphomaDecember 14th, 2022- Novel Vaccine Approach Halts Disease After 23 Years of Breast CancerDecember 10th, 2022
- Getting Closer to a Vaccine for CancerJune 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
